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The coat protein complex II (COPII) is essential for vesicle
formation from the endoplasmic reticulum (ER) and is
composed of two heterodimeric subcomplexes, Sec23p/
Sec24p and Sec13p/Sec31p, and the small guanosine
triphosphatase Sar1p. In an effort to identify novel factors
that may participate in COPII vesicle formation, we iso-
lated SMY2, a yeast gene encoding a protein of unknown
function, as a multicopy suppressor of the temperature-
sensitive sec24-20mutant.Wefound thateven alow-copy
expression of SMY2 was sufficient for the suppression of
the sec24-20 phenotypes, and the chromosomal deletion
of SMY2 led to a severe growth defect in the sec24-20
background. In addition, SMY2 exhibited genetic inter-
actions with several other genes involved in the ER-to-
Golgi transport. Subcellular fractionation analysis
showed that Smy2p was a peripheral membrane protein
fractionating together with COPII components. However,
Smy2p was not loaded onto COPII vesicles generated
in vitro. Interestingly, coimmunoprecipitation between
Smy2p and the Sec23p/Sec24p subcomplex was specifi-
cally observed in sec23-1 and sec24-20 backgrounds,
suggesting that this interaction was a prerequisite for
the suppression of the sec24-20 phenotypes by over-
expression of SMY2. We propose that Smy2p is located
on the surface of the ER and facilitates COPII vesicle
formation through the interaction with Sec23p/Sec24p
subcomplex.
Key words: coat protein complex II, endoplasmic reticu-
lum, multicopy suppressor, Saccharomyces cerevisiae,
SEC24, vesicle formation
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In eukaryotic cells, protein transport along the secretory
pathway is mediated by transport vesicles, which emerge
from a donor organelle and fuse with an appropriate target
organelle. Newly synthesized secretory proteins are cor-
rectly folded in the endoplasmic reticulum (ER), which is
the starting point of the secretory pathway, and then
exported to the Golgi apparatus by coat protein complex
II (COPII)-coated vesicles (1). COPII coat is essential for
vesicle formation from the ER membrane and is composed
of the small guanosine triphosphatase (GTPase) Sar1p (2)
and heterodimeric subcomplexes, Sec23p/Sec24p and
Sec13p/Sec31p (3). The vesicle formation starts with the
conversion of inactive Sar1p-GDP to active Sar1p-GTP by
Sec12p, the guanine-nucleotide exchange factor (GEF) for
Sar1p, localized on the ER membrane (4,5). Sar1p-GTP
binds to the ER membrane and then sequentially recruits
Sec23p/Sec24p and Sec13p/Sec31p to form a bud that is
finally pinched off as a COPII vesicle (3). After formation,
COPII vesicles lose their coats, and the resulting naked
vesicles undergo tethering, docking and fusion to the Golgi
membrane (6). Coat disassembly requires GTP hydrolysis
of Sar1p, which is stimulated by Sec23p, the GTPase
activating protein (GAP) for Sar1p (7,8).
In addition to COPII vesicle formation, packaging of cargo
molecules into vesicles is driven by the Sar1p–Sec23p/
Sec24p prebudding complexes (9–11). Recent studies
demonstrate that Sec24p contains several cargo-binding
sites on its membrane-proximal surface and acts as the
coat for cargo selection (12–14). The Sec24p ‘A-site’ re-
cognizes YxxxNPF motif on the soluble n-ethylmaleimide-
sensitive fusion protein attachment protein receptor
(SNARE), Sed5p, and the ‘B-site’ binds multiple motifs:
Lxx(L/M)E on the SNAREs, Sed5p and Bet1p, and (D/
E)x(D/E) on the Golgi protein Sys1p (13,14). The ‘C-site’
binds the SNARE Sec22p byrecognizing its conformational
epitope (13–15). Moreover, the existence of Sec24p sub-
types in both yeast and mammals expands the cargo
multiplicity captured by COPII coat (16–21). For example,
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homologues, Sfb2p (Iss1p) (56% identity) and Sfb3p (Lst1p)
(23% identity), both of which can form a complex with
Sec23p (16–19). Sfb3p is specialized for efficient packag-
ing of the plasma membrane proton adenosine triphos-
phatase Pma1p into COPII vesicles (22), and chromosomal
disruption of SFB3 results in the pH-sensitive growth
defect because of the arrest of Pma1p in the ER (19). In
contrast, Sfb2p appears to be a functionally redundant
Sec24p homologue because its overproduction not only
suppresses the temperature-sensitive phenotypes of the
sec24 mutants but also replaces the essential gene
SEC24 (16–18).
Reconstitution studies have demonstrated that COPII
components themselves are minimal requirements to
drive vesicle formation from chemically defined liposomes
(23–25). Although dispensable for the reconstitution, there
are additional proteins involved in COPII vesicle formation
in vivo: Sec16p, Sed4p and the Yip1p–Yif1p–Yos1p com-
plex. Sec16p is a large, hydrophilic protein that associates
peripherally with the ER membrane and can bind with
Sec23p, Sec24p and Sec31p through its distinct domains
(26–28). Sec16p is shown to bind to liposomes and
facilitates the recruitment of COPII components and the
following vesicle formation without regulating Sar1p-GTP
hydrolysis (29), indicating that Sec16p is a scaffold for the
assembly of COPII coats. In yeast Pichia pastoris and
mammalian cells, Sec16p localizes to discrete subdomains
of the ER termed transitional ER or ER exit sites and is
involved in their organization as well as COPII vesicle
formation (30,31). Sed4p is an integral membrane protein
localized on the ER, whose cytoplasmic domain shares
45% identity with that of Sec12p (32). SED4 exhibits
genetic interactions with SEC12, SEC16 and SAR1
(33,34), and chromosomal disruption of SED4 results in
a decreased rate of ER-to-Golgi transport (33), suggesting
the involvement of Sed4p in COPII vesicle formation.
Finally, Yip1p is an integral membrane protein previously
found to interact with several Rab GTPases including
Ypt1p (35,36) and forms a heterodimeric complex with
its homologue Yif1p (37). From the observations that YIP1
exhibits genetic interactions with SEC12, SEC13 and
SEC23 and that ER membranes from the temperature-
sensitive yip1 allele show reduced COPII vesicle formation
in vitro, Yip1p is likely implicated in COPII vesicle formation
(38). Moreover, the Yip1p–Yif1p complex forms a ternary
complex with another integral membrane protein Yos1p,
whose defect also shows reduced COPII vesicle formation
in vitro (39). Like Sec16p, Yip1A, a mammalian homologue
of Yip1p, localizes to ER exit sites (40). Thus, it seems
likely that the process by which COPII vesicles are formed
is more complex in vivo than in vitro, and these observa-
tions prompt us to investigate other unknown proteins
involved in COPII vesicle formation.
In this report, we characterized SMY2, a high-copy sup-
pressor of the temperature-sensitive sec24-20 mutant.
While Sec24-20p can form a complex with Sec23p, the
sec24-20 mutation results in the severe blockage in ER-to-
Golgi transport and the significant accumulation of the ER
membrane without obvious vesicle accumulation at the
restrictive temperature, strongly suggesting the defects in
COPII vesicle formation (17). Our genetic and biochemical
evidence suggests the involvement of Smy2p in COPII
vesicle formation.
Results
SMY2 is a novel suppressor of the sec24-20 mutant
We screened a YEp13 (LEU2, 2m)-based yeast geno-
mic DNA library (41) for high-copy suppressors of the
temperature-sensitive sec24-20 mutant and repeatedly
obtained plasmids that harbored a genomic fragment
containing six complete open reading frames (ORFs),
YBR171w to YBR176w. After subcloning, YBR172c was
found to be responsible for the suppression. This ORF
remained to be characterized; however, it had already
been named SMY2 (suppressor of myosin 2) because of
its previous identification as a high-copy suppressor of the
temperature-sensitive myosin V mutant myo2-66 (42).
Thus, we hereafter call this ORF SMY2.
As shown in Figure 1A, the high-copy (2m) and low-copy
(CEN) plasmids containing SMY2 suppressed the growth
defect of sec24-20 cells to the same extent at the restric-
tive temperature of 338C. To directly observe whether the
overexpression of SMY2 rescues the ER-to-Golgi transport
defect of sec24-20 cells, we performed pulse–chase analy-
sis of a vacuolar protein carboxypeptidase Y (CPY) and a
glycosylphosphatidylinositol-anchored plasma membrane
protein Gas1p (Figure 1B). Newly synthesized CPY is de-
tected as the p1 precursor form (67 kDa) in the ER, further
modified to the p2 form (69 kDa) in the Golgi and then
proteolytically processed to the mature form (m; 61 kDa)
in the vacuole (43). Similarly, Gas1p is detected as the
105-kDa precursor form (p) in the ER, further modified to
the 125-kDa mature form (m) in the Golgi and then
delivered to the plasma membrane (44,45). As shown in
Figure 1B, sec24-20 cells exhibited severe maturation
defects of both proteins and accumulated their ER forms
(p1 of CPY and p of Gas1p) at the restrictive temperature of
338C. These defects were partially suppressed by either
high-copy (2m) or low-copy (CEN) SMY2 plasmid. These
results indicate that even the low-copy (CEN) expression
of SMY2 is sufficient for the suppression of temperature-
sensitive sec24-20 phenotypes. As far as we examined, the
overexpression of SMY2 affected neither growth nor ER-
to-Golgi transport in wild-type cells (data not shown).
We previously showed that overexpression of SFB2
(ISS1) suppresses the sec24-20 phenotypes (17). To ad-
dress the relationship between SMY2 and SFB2,w ee x a m -
ined whether overexpression of SMY2 suppresses the
temperature-sensitive growth defect of the sec24-20
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somal disruption of SFB2 did not exacerbate the temper-
ature-sensitive growth defect of the sec24-20 cells (data
not shown). Both the high-copy (2m) and the low-copy
(CEN) expression of SMY2 suppressed the growth defect
of sec24-20Dsfb2 cells at the restrictive temperature of
338C (Figure 1C), indicating that endogenous Sfb2p is not
involved in the suppression by overexpression of SMY2.
We therefore concluded that SMY2 is a novel suppressor
of the sec24-20 mutant.
Smy2p and its homologue Ypl105cp
SMY2 encodes a 790 amino acid residue protein with
a predicted molecular mass of 87 kDa. As shown in
Figure 2A, Smy2p is predicted to contain a GYF domain,
a proline-rich sequence binding module (46,47), and
a coiled-coil region by the SMART program (48,49). Its
hydropathy profile indicates that Smy2p is a hydrophilic
protein containing neither signal sequence nor transmem-
brane domain (Figure 2B). The Saccharomyces genome
also contains an uncharacterized ORF YPL105c encoding
an 849 amino acid residue protein with 30% overall identity
to Smy2p (Figure 2A) (48–50). Besides the GYF and coiled-
coil domains, the region corresponding to carboxy-terminal
100 amino acids is highly conserved between Smy2p and
Ypl105cp. However, overexpression of YPL105c failed to
suppress the temperature-sensitive growth defect of
sec24-20 cells (Figure 2C). To determine whether SMY2
and YPL105c are required for growth, we constructed a
diploid strain that one copy of each gene was disrupted.
Figure 1: Suppression of sec24-
20 phenotypes by overexpres-
sion of SMY2. A) Wild-type (WT;
YNH1) and sec24-20 (YNH2) cells
were transformed with pSMY1
(SMY2, 2m), pSMY3 (SMY2, CEN)
or pRS426 (vector). Tenfold serial
dilutions (starting from A600 of 0.1)
of the transformants were spotted
on MVD plates and incubated at the
indicated temperatures for 3 days.
B) The transformants used in A
were incubated at 238Co r3 3 8C for
20 min, pulse labeled with [
35S]-
methionine/cysteine for 10 min
and chased for the indicated times.
After preparing cell lysates, CPY
and Gas1p were immunoprecipi-
tated, resolved by SDS–PAGE and
visualized with a BAS2500 image
analyzer. The different maturation
forms of CPY (p1, ER form; p2,
Golgi form; m, mature form in the
vacuole) and Gas1p (p, ER form; m,
mature form beyond the Golgi) and
relative amounts of those mature
forms at 338C are indicated. C)
sec24-20 (YNH7) and sec24-
20Dsfb2 (YNH8) cells were trans-
formed with pSMY1 (SMY2, 2m),
pSMY3 (SMY2, CEN) or pRS426
(vector). The transformants were
streaked onto MVD plates and incu-
bated at the indicated temperatures
for 3 days.
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double disruption of the genes affects growth or ER-to-
Golgi transport (data not shown).
Chromosomal disruption of SMY2 exhibits a synthetic
lethal interaction with the sec24-20 mutation
To further examine the genetic interaction between SEC24
and SMY2, we tested whether the chromosomal disrup-
tion of SMY2 affects the growth phenotype of the sec24-
20 mutant. First, the chromosomal disruption of SMY2
(Dsmy2) was introduced into a yeast strain YKH3, which
contained the sec24 null (Dsec24) mutation but was res-
cued by the plasmid pSEC24 (pAN1; SEC24, CEN, URA3),
to generate a new yeast strain YNH3 (Dsec24Dsmy2).
Dsec24 (YKH3) and Dsec24Dsmy2 (YNH3) strains were
then transformed with the plasmid psec24-20 (pAN12;
sec24-20, CEN, TRP1), and the resulting transformants
were streaked onto selective media (MVD) plates contain-
ing 5-fluoroorotic acid (5-FOA), which allow only the cells
lacking the functional URA3 gene to grow. As shown in
Figure 3, Dsec24 (YKH3) cells containing psec24-20
(pAN12; sec24-20, CEN, TRP1) grew on 5-FOA plates,
indicating that pSEC24 (pAN1; SEC24, CEN, URA3) was
replaced by psec24-20 (pAN12; sec24-20, CEN, TRP1)t o
rescue the sec24 null mutation. However, Dsec24Dsmy2
(YNH3) cells containing psec24-20 (pAN12; sec24-20,
CEN, TRP1) failed to grow on 5-FOA plates, indicating that
the plasmid replacement was not achieved in the absence
of SMY2 and that the sec24-20 mutation is synthetically
lethal with the chromosomal disruption of SMY2.
SMY2 exhibits genetic interactions with several
genes involved in the ER-to-Golgi transport
The strong genetic interaction with SEC24 prompted us
to examine whether SMY2 also exhibits interactions
with other genes involved in vesicular transport. First,
Figure 2: Smy2p and Ypl105cp.
A) Schematic representation of
Smy2p and its homologue Ypl105cp
indicating conserved regions and
consensus motifs present at com-
parable sites. Amino acid sequen-
ces around the GYF domain of
Smy2p and consensus sequence
of the domain are also indicated.
B) Hydropathy profile of Smy2p
calculated as described by Kyte
and Doolittle (72). C) sec24-20
(YNH2) cells containing pSMY1
(SMY2, 2m), pYPL1 (YPL105c, 2m)
or pRS426 (vector) were streaked
onto MVD plates and incubated at
the indicated temperatures for
3 days. The amino acids underlined
denote the consensus motif of the
GYF domain.
Figure 3: SMY2 disruption exhi-
bits severe growth defect in the
sec24-20 background. Dsec24 cells
being rescued by pSEC24 (pAN1;
SEC24, CEN, URA3) (YKH3) and
Dsec24Dsmy2 cells being rescued
by pSEC24 (pAN1; SEC24, CEN,
URA3) (YNH3) were transformed
with psec24-20 (pAN12; sec24-20,
CEN, TRP1) or pRS314 (vector). The
transformants were streaked onto
MVD (control) and MVD containing
5-FOA (5-FOA) plates and incubated
at 238C for 3 days.
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various temperature-sensitive mutants defective in vesic-
ular transport between the ER and the Golgi, and the
suppression activity was tested (Table 1). The high-copy
(2m) expression of SMY2 suppressed the temperature-
sensitive growth defect of the following mutants defective
in ER-to-Golgi transport: sec16-2 (COPII vesicle formation),
sec22-3 and bet1-1 (ER–Golgi SNAREs), and sec34-1 and
sec35-1 (vesicle tethering to the Golgi), but not mutants
defective in vesicle fusion or Golgi-to-ER transport. The
low-copy (CEN) expression of SMY2 could suppress only
the growth defect of sec24-20.
We then examined whether the chromosomal disruption
of SMY2 affects the temperature-sensitive growth of
mutants defective in ER-to-Golgi transport. Among the
strains tested, we found that Dsmy2 exhibited weak
synthetic negative interactions with sec13-1 (COPII vesicle
formation) and sec22-3 (ER–Golgi SNARE) (data not
shown).
Together, our genetic observations suggest that SMY2
is involved in the ER-to-Golgi transport, especially in the
COPII vesicle formation.
Smy2p localization
To examine the intracellular distribution of Smy2p, three
repeats of the influenza virus hemagglutinin (HA) epitope
were tagged at its carboxyl terminus. Epitope-tagged
SMY2 (SMY2-3HA) was judged to be functional because
Table 1: Effect of SMY2 overexpression on the growth of temperature-sensitive mutants defective in vesicular transport between the
ER and the Golgi
a
Function Strain Plasmid
Incubation temperature (8C)
26 28 30 32 34 35 37
COPII vesicle formation sec12-4 vector þþþ    
SMY2(2m) þþþþ   
sar1-2 vector þþþþþþ 
SMY2(2m) þþþþþþ 
sec23-1 vector þþ     
SMY2(2m) þþ     
sec23-2 vector þþþ    
SMY2(2m) þþþ    
sec13-1 vector þþþ    
SMY2(2m) þþþþ   
sec24-20 vector þþ     
SMY2(2m) þþþþþþ 
sec31-1 vector þþþþþþ 
SMY2(2m) þþþþþþþ
sec16-2 vector þþ     
SMY2(2m) þþþþ   
ER–Golgi SNAREs sec22-3 vector þþ     
SMY2(2m) þþþþþ  
bet1-1 vector þþþþ   
SMY2(2m) þþþþþþþ
Vesicle tethering
to the Golgi
sec34-1 vector þþþ    
SMY2(2m) þþþþþþþ
sec35-1 vector þþþ    
SMY2(2m) þþþþþ  
Vesicle fusion sec17-1 vector þþþþ   
SMY2(2m) þþþþ   
sec18-1 vector þ      
SMY2(2m) þþ     
Golgi-to-ER transport sec20-1 vector þþ     
SMY2(2m) þþ     
sec21-1 vector þþþ    
SMY2(2m) þþþ    
sec27-1 vector þþ     
SMY2(2m) þþþ    
ret1-1 vector þþþþþ  
SMY2(2m) þþþþ   
ret3-1 vector þþþþ   
SMY2(2m) þþþþ   
aMutants containing pSMY1 (SMY2, 2m) or pRS426 (vector) were incubated on MVD plate for 3–4 days at the indicated temperatures,
respectively.
Traffic 2008; 9: 79–93 83
Role of Smy2p in COPII Vesicle Formationit suppressedthe sec24-20 phenotypes to thesame extent
as untagged SMY2 (data not shown). SMY2-3HA was
introduced into Dsmy2 (YNH4) strain by either a low-copy
(CEN) or a high-copy (2m) vector, and whole cell lysates
prepared from the transformants were analyzed by immuno-
blotting with the anti-HA antibody (Figure 4A). Smy2-3HAp
was detected as aprotein with apparentmolecular mass of
100 kDa that is higher than the predicted molecular mass
of 87 kDa, probably because of its high isoelectric point of
8.97 as predicted by its amino acid composition. While the
suppression activity for the sec24-20 mutation was com-
parable (Figure 1A), the low-copy (CEN) SMY2-3HA plas-
mid gave much lower expression of Smy2-3HAp than the
high-copy (2m) plasmid.
Smy2p is predicted to be a hydrophilic protein containing
neither signal sequence nor transmembrane domain (Fig-
ure 2B). To examine possible membrane association of
Smy2p, the whole cell lysate from Dsmy2 (YNH4) cells
containing the low-copy (CEN) SMY2-3HA plasmid was
subjected to 100 000   g centrifugation, and the resulting
supernatant (S1) and pellet (P1) fractions were analyzed by
immunoblotting (Figure 4B). Unexpectedly, whereas the
peripheral membrane protein Sec24p was detected in both
S1 and P1 fractions, Smy2-3HAp was detected only in the
P1 fraction like the integral membrane protein Dpm1p
(51,52). To further examine the nature of membrane
association of Smy2p, the P1 fraction was treated with
buffer containing 0.5 M NaCl (NaCl), 2.5 M urea (Urea),
0.1 M Na2CO3 (pH 11) or 1% Triton-X-100 (TX100), centri-
fuged at 100 000   g to separate the supernatant (S2) and
pellet (P2) fractions and then analyzed by immunoblotting.
As shown in Figure 4C, the integral membrane protein
Dpm1p was solubilized only by 1% Triton-X-100, but
Smy2-3HAp was efficiently solubilized by 2.5 M urea or
0.1 M Na2CO3 as the peripheral membrane protein
Sec24p. These results strongly suggest that Smy2p is
a peripheral membrane protein with no soluble pool, but
not an integral membrane protein.
As our genetic observation suggests the involvement of
Smy2p in COPII vesicle formation, the most plausible
intracellular localization of Smy2p may be the ER mem-
brane. To address this, the 100 000   g pellet fraction of
the lysate was subjected to a subcellular fractionation
analysis by velocity sedimentation on a sucrose density
gradient, and the distribution of Smy2-3HAp was com-
pared with that of marker proteins of the ER and the Golgi
by immunoblotting (Figure 5A). Notably, Smy2-3HAp was
cosedimented with COPII components Sec24p and
Sec31p in the fractions 8–10 in which the ER marker
Sec61p was more abundant than the Golgi marker Kex2p.
This result suggests that Smy2p is localized on the surface
of the ER together with COPII components. Similar results
were obtained from the subcellular fractionation analysis
by flotation equilibrium in a sucrose density gradient,
confirming that Smy2p associates with membranes but
not with cytoskeletons (data not shown).
Finally, we examined the intracellular localization of Smy2p
by microscopic analysis. Dsmy2 (YNH4) cells containing the
low-copy (CEN) SMY2-3HA plasmid were subjected to in-
direct immunofluorescence analysis with the anti-HA anti-
body. As shown in Figure 5B, many, if not all, cells exhibited
concentratedstainingaround the4,6-diamino-2-phenylindole
(DAPI)-stained nucleus, reminiscent of the perinuclear
Figure 4: Smy2p is a peripheral membrane protein. A) Whole cell lysates (45 mg protein equivalents) from Dsmy2 (YNH4) cells
containing pSMY4 (SMY2-3HA, CEN), pSMY2 (SMY2-3HA, 2m) or pRS316 (vector) were resolved by SDS–PAGE and immunoblotted with
the anti-HA or anti-Sec24p antibody.B) A whole cell lysate from Dsmy2 (YNH4) cells containing pSMY4 (SMY2-3HA, CEN) was centrifuged
at 100 000   g, and the resulting supernatant (S1) and pellet (P1) fractions were resolved by SDS–PAGE and immunoblotted with the anti-
HA, anti-Sec24p or anti-Dpm1p antibody. C) Aliquots of the P1 fraction were treated with buffer, buffer containing 0.5 M NaCl (NaCl), 2.5 M
urea (Urea), 0.1 M Na2CO3 (pH 11) or 1% Triton-X-100 (TX100). Samples were centrifuged at 100 000   g, and the resulting supernatant
(S2) and pellet (P2) fractions were analyzed as in B.
84 Traffic 2008; 9: 79–93
Higashio et al.localization of ER-resident proteins (53,54). In addition,
cells often exhibited weak punctate staining dispersed in
the cell body. This staining pattern of Smy2-3HAp was
similar to that of Sec16p, a peripheral membrane protein
localized on the ER (26).
Together, these biochemical and morphological observa-
tions suggest that Smy2p is a peripheral membrane pro-
tein associated with the COPII-enriched ER membrane.
Smy2p is not present on COPII vesicles formed
in vitro
Is Smy2p incorporated into COPII vesicles or statically
localized on the ER? To address this, we performed an
in vitro vesicle budding assay with purified COPII compon-
ents and salt-washed microsomes, which were prepared
from Dsmy2 (YNH4) cells containing the low-copy (CEN)
SMY2-3HA plasmid. The salt wash allowed Smy2-3HAp to
remain associated with microsomes. As shown in Figure 6,
the ER–Golgi SNARE Sec22p was efficiently incorporated
into vesicle fraction, but Smy2-3HAp and the negative
control Sec61p were not. Thus, Smy2p is likely to localize
statically on the ER membrane.
We tried to compare the efficiency of vesicle formation
among the salt-washed microsomes, which were pre-
pared from YNH4 (Dsmy2) cells containing the low-copy
(CEN)o rt h eh i g h - c o p y( 2m) SMY2-3HA plasmid or an
empty vector. As far as we examined, however, no dif-
ference was observed under our experimental conditions
Figure 5: Smy2p is localized on ER membrane. A) A whole cell lysate from Dsmy2 (YNH4) cells containing pSMY4 (SMY2-3HA, CEN)
was centrifuged at 100 000   g. The resulting pellet fraction (mem) was resuspended in sucrose solution and separated on a 20–60%
sucrose density gradient. Twelve fractions were collected from the top, resolved by SDS–PAGE and immunoblotted with the anti-HA, anti-
Sec24p, anti-Sec31p, anti-Sec61p or anti-Kex2p antibody. Relative amounts of these proteins in each fraction were quantified by
densitometry of immunoblots. B) Yeast cells used in A were examined by indirect immunofluorescence with the anti-HA antibody (left
panels in the pair). DAPI staining was used to visualize the nuclei (right panels in the pair).
Figure 6: Smy2p is not incorporated into COPII vesicles. Salt-
washed microsomes prepared from Dsmy2 (YNH4) cells contain-
ing pSMY4 (SMY2-3HA, CEN) were incubated with (þ) or without
( ) purified COPII proteins in the presence of guanyl-50-yl imido-
diphosphate. One tenth of the total reaction (T) and the budded
COPII vesicles separated from donor membranes by centrifuga-
tion were resolved by SDS–PAGE and immunoblotted with anti-
HA, anti-Sec22p or anti-Sec61p antibody. Relative amounts of
these proteins incorporated into COPII vesicles were quantified
by densitometry of immunoblots.
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formation (data not shown).
Smy2p and a COPII subcomplex, Sec23p/Sec24p, are
coimmunoprecipitated in specific COPII mutants
The results obtained so far support the idea that Smy2p
might be functioning during COPII vesicle formation
together with COPII components, especially with Sec24p.
We therefore decided to examine whether Smy2p phys-
ically interacts with COPII components. In order to inves-
tigate their biochemical interaction in various mutant
backgrounds, we performed coimmunoprecipitation ex-
periments using Triton-soluble fractions of whole cell
lysates, even though they contained small amounts of
soluble Smy2-3HAp and COPII components (Figure 4).
First, whole cell lysates from wild-type (YNH1) and
sec24-20 (YNH2) cells containing the low-copy (CEN)
SMY2-3HA plasmid (cultured at 238C) were solubilized by
1% Triton-X-100, centrifuged at 17 400   g for 30 min at
48C and the resulting supernatants were subjected to
immunoprecipitation with the anti-HA antibody. Immuno-
precipitates were then analyzed by immunoblotting with
antibodies against COPII components. As shown in Fig-
ure 7A, we were able to pull down Smy2-3HAp with the
anti-HA antibody from the Triton-soluble fractions of both
strains and found that Sec24p and Sec23p, but not
Sec31p, were coimmunoprecipitated with Smy2-3HAp in
thesec24-20 mutantbackground. In contrast,no coimmuno-
precipitation was observed in the wild-type background.
Next, to examine whether this protein–protein interaction
is specific for the sec24-20 background or is a general
consequence of the reduced ER-to-Golgi transport, we
performed the coimmunoprecipitation experiments using
the Triton-soluble fractions of whole cell lysates prepared
from the following temperature-sensitive mutants defective
in ER-to-Golgi transport (cultured at 238C): sec12-4, sec13-1,
sec16-2, sec23-1, sec24-20 (COPII vesicle formation),
sec34-1, sec35-1 (vesicle tethering to the Golgi) and
sec22-3 (ER–Golgi SNARE), which contain the low-copy
(CEN) SMY2-3HA plasmid. Again, Smy2-3HAp was suc-
cessfully recovered from the Triton-soluble fractions from all
strains tested (Figure 7B). Surprisingly, the coimmunopreci-
pitation was observed in sec23-1 and sec24-20,b u tn o ti n
other mutant backgrounds. Similar results were obtained
from whole cell lysates from the mutants incubated at the
restrictive temperature of 338C at which the ER-to-Golgi
transport is severely inhibited (data not shown). These
results strongly suggest that the fraction of Smy2-3HAp
Figure 7: COPII subcomplex Sec23p/
Sec24p is coprecipitated with Smy2p
in sec23 and sec24 backgrounds. A)
Whole cell lysates from wild-type (WT;
YNH1) and sec24-20 (YNH2) cells contain-
ing pSMY4 (SMY2-3HA, CEN) or pRS316
(Vector)(culturedat238C)weresolubilized
with 1% Triton-X-100. After centrifugation
at 17 400   g for 30 min at 48C, super-
natantsweresubjectedtoimmunoprecipi-
tation with (þ) or without ( ) the anti-HA
antibody.The lysates (Lysate)and immuno-
precipitates (IP) were resolved by SDS–
PAGE and immunoblotted (IB) with the
anti-HA, anti-Sec24p, anti-Sec23p or anti-
Sec31p antibody. B) Whole cell lysates
from sec12-4 (MBY10-7A), sec23-1
(RSY282), sec24-20 (YNH2), sec13-1
(RSY266), sec16-2 (RSY268), sec34-1
(YNH5), sec35-1 (YNH6) and sec22-3
(RSY942) cells containing pSMY4 (cultured
at 238C) were analyzed by immunopre-
cipitation as in A.
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ing with the Sec23p/Sec24p subcomplex only in the
sec24-20 or sec23-1 background, which seems to be
a specific consequence of the dysfunction of Sec23p or
Sec24p, rather than the general consequence of reduced
ER-to-Golgi transport.
Two-hybrid interaction between Smy2p and Sec23p
The interaction between Smy2p and the Sec23p/Sec24p
subcomplex was also examined by the yeast two-hybrid
system. Smy2p was fused to the LexA-DNA binding
domain and tested for interaction with Sec23p and
Sec24p, which were connected to the B42 acidic acti-
vation domain. Interaction was detected by the level of
b-galactosidase expression in yeast from a LacZ reporter
gene carrying LexA operator sites in the promoter. Unex-
pectedly, interaction was detected between Smy2p and
Sec23p, but not between Smy2p and Sec24p (Table 2).
The b-galactosidase activity for this interaction was much
lower than that for the highly stable interaction between
Sec23p and Sec24p (as a positive control), suggesting that
Smy2p weakly or transiently associates with Sec23p.
Nevertheless, this two-hybrid interaction seems to repre-
sent, at least, a part of the nature of coimmunoprecipita-
tion between Smy2p and the Sec23p/Sec24p subcomplex.
Overexpression of Smy2p suppresses the sec24-20
phenotypes through the interaction with
Sec23p/Sec24p subcomplex
We performed a mutational analysis of Smy2p to identify
the regions required for the suppression of sec24-20
phenotypes and for the interaction with Sec23p/Sec24p
subcomplex. First, a series of mutant smy2 genes with
3HA epitopeat theircarboxyl termini wereconstructed and
introduced on the low-copy (CEN) vector into sec24-20
(YNH2) cells to examine their suppression activity (Fig-
ure 8A). The suppression activity was severely reduced
when the consensus sequence of the GYF domain (GPF-
X7-W-X3-GYF) was disrupted by amino acid substitutions
(mutant A) or deletion (mutant B). The deletion of the
coiled-coil domain did not affect the suppression activity
(mutant C). We also found that the amino-terminal region
alone, which contained the GYF domain (amino acid
residues 1–336), exhibited a low level of suppression
activity (mutant D), and this was restored to the wild-type
level by fusion with the carboxyl-terminal portion contain-
ing amino acid residues 501–676 (mutant F) but not with
residues 677–790 (mutant E). Another amino- and car-
boxyl-terminal fusion containing amino acid residues 1–
500 and 677–790 also showed a high suppression activity
(mutant G). However, the carboxyl-terminal portion alone
was insufficient for the suppression (mutants H and I).
These results suggest that the combination of the intact
GYF domain and a certain length of the carboxyl-terminal
domain is required for the suppression.
We then examined whether these mutant Smy2p interact
with Sec23p/Sec24p subcomplex by coimmunoprecipita-
tion analysis in the sec24-20 background as described
above. As shown in Figure 8B, the Sec23p/Sec24p sub-
complex was coimmunoprecipitated with the GYF mu-
tants (mutants A and B) or the coiled-coil mutant (mutant
C), suggesting that these domains are not involved in the
interaction. Notably, the amino-terminal portion alone
(amino acid residues 1–336) failed to coimmunoprecipitate
Sec23p/Sec24p (mutant D), and the fusion with a certain
length of the carboxyl-terminal portion restored the coim-
munoprecipitation (mutants F and G). Again, the carboxyl-
terminal portion alone exhibited no coimmunoprecipitation
(mutants H and I). These results suggest that neither the
GYF nor the coiled-coil domain alone, but a larger part of
Smy2p, is required for the interaction with Sec23p/Sec24p
subcomplex.
Taken together, these genetic and biochemical analyses
indicate that all mutant Smy2p with the suppression
activity could coimmunoprecipitate Sec23p/Sec24p and
that the strength of the suppression well correlated with
theamountofthe Sec23p/Sec24psubcomplexcoimmuno-
precipitated. Thus, the interaction between Smy2p and
the Sec23p/Sec24p subcomplex is probably a prerequisite
for the suppression of the sec24-20 phenotypes by
overexpression of SMY2.
Discussion
In this study, we isolated SMY2 as a suppressor of the
temperature-sensitive sec24-20 mutant. We first excluded
the possibility that endogenous Sfb2p (Iss1p), a functionally
redundantSEC24homologue,isinvolvedinthesuppression
Table 2: Two-hybrid interaction between Smy2p and Sec23p
a
B42 acidic activation domain fused to
no fusion SEC23 SEC24
LexA-DNA binding domain fused to no fusion 4.58   0.54 1.09   0.45 2.11   1.32
SMY2 3.57   1.21 26.03   11.15 1.62   0.53
SEC24 7.53   1.77 401.40   41.23 Not determined
ab-Galactosidase activity (units). EGY48 cells containing plasmids encoding a LexA fusion protein (pEG202, pEG-SMY2 or pEG-SEC24),
a B42 fusion protein (pJG4-5, pJG-SEC23 or pJG-SEC24) and a reporter plasmid (pSH18-34) were grown in raffinose/galactose medium
for 10 h before the assay to induce expression of B42 fusion proteins.
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that the suppression involves endogenous Sfb3p (Lst1p)
as its overexpression cannot suppress the temperature-
sensitive growth defect ofthe sec24 mutants (17,18). Thus,
we concluded that SMY2 is a novel suppressor of the
sec24-20 mutant and further characterized its properties.
The Saccharomyces genome contains the SMY2 homo-
logue YPL105c (48–50), but its overexpression failed to
suppress any mutants defective in vesicular transport
between the ER and the Golgi (Figure 2C and our
unpublished observation). In addition, immunofluores-
cence staining of Ypl105c-3HAp did not show the peri-
nuclear ER-like pattern, as was the case with Smy2-3HAp
(our unpublished observation). Thus, we consider that
despite the sequence similarity, Ypl105cp is not the
functional Smy2p homologue.
Genetic analysis revealed that all mutations suppressed
by the high-copy (2m) expression of SMY2 are linked to
the ER-to-Golgi transport (Table 1). SMY2 exhibited par-
ticularly strong genetic interaction with SEC24 (Figures 1
and 3). This may suggest that Smy2p functions co-
operatively with Sec24p in COPII vesicle formation.
However, considering other mutations suppressed by
the high-copy (2m) expression of SMY2, other possibilities
cannot be ruled out. For example, Smy2p might function
in tethering (sec34-1 and sec35-1)a n d / o rf u s i o n( sec22-3
and bet1-1) of ER-derived vesicle to the Golgi membrane.
The intimate relationship between COPII vesicle forma-
tion and vesicle tethering/fusion to the Golgi membrane
in mammalian cells (55) also leaves a possibility that
Smy2p might affect indirectly on these aspects of ER-to-
Golgi transport from the stage of COPII vesicle formation
in yeast.
Figure 8: Mutational analysis of Smy2p. A) Schematic representation of mutant Smy2p. The amino acid numbers corresponding to
boundaries of each fragment are indicated. Each smy2 construct was introduced into sec24-20 (YNH2) cells with a low-copy vector
pRS316 (URA3, CEN), and its suppression activity was examined as in Figure 1A. After three independent experiments, the relative
strength of suppression was indicated for each construct. B) Whole cell lysates from the transformants used in A (cultured at 238C) were
analyzed by immunoprecipitation as in Figure 7A. The underlined indicate the original amino acid residues in the WT GYF domain and the
corresponding mutated amino acid residues in Mutant A.
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Smy2p is a peripheral ER membrane protein cofractionated
with COPII components (Figures 4 and 5). However, in vitro
vesicle budding assay revealed that Smy2p is not incorpor-
ated into COPII vesicles (Figure 6), suggesting that Smy2p
acts as neither coat nor cargo protein, but is statically
localized on the ER and facilitates COPII vesicle formation.
Coimmunoprecipitation analysis revealed that Smy2p spe-
cifically interacts with the Sec23p/Sec24p subcomplex in
sec24-20 and sec23-1 mutants (Figure 7). This observation
may represent prolonged interaction of the proteins in
these mutant backgrounds and implies that Smy2p assists
some Sec23p/Sec24p-deficient process during COPII ves-
icle formation, while the interaction may be too transient to
be detected by coimmunoprecipitation in wild-type cells.
We further found that the interaction between Smy2p and
the Sec23p/Sec24p subcomplex appears to be a prerequi-
site for the suppression of the sec24-20 phenotypes by
overexpression of SMY2 (Figure 8). What is then the
mechanism of the suppression? The sec24-20 gene has
a mutation by which the 897th codon (TGG) encoding
tryptophan (W897) is changed to a termination codon
(TGA) (our unpublished observation), resulting in producing
Sec24-20p, a truncated Sec24p lacking the carboxyl-
terminal 30 amino acids. This short carboxyl-terminal region
is shown to locate on the membrane-proximal surface (56).
Moreover, W897 is located in the cargo recognition ‘A-site’
and is shown to be important for Sed5p binding (13,14,57).
As the sec24-20 mutant exhibits growth arrest and the
blockage of ER-to-Golgi transport at the restrictive tempera-
ture, without obvious accumulation of vesicles (17), we
consider that the Sec23p/Sec24-20p subcomplex probably
becomes defective in COPII vesicle formation at high
temperatures because of the weakened interaction with
membranes and/or membrane proteins such as Sed5p. If
this is the case, the suppression by excess Smy2p could be
accounted for bythepossibilitythat Smy2pacts as ascaffold
or a platform for the assembly of COPII coat, which directly
binds Sec23p/Sec24p, like the essential scaffold protein
Sec16p (26–29). An increased amount of Smy2p may pro-
vide the additional scaffold or platform, leading to the
compensation for the impaired function of Sec23p/Sec24-
20p. This idea is supported by the suppression of the sec16-
2 mutation by the high-copy (2m) expression of SMY2
(Table 1) and the two-hybrid interaction between Smy2p
and Sec23p (Table 2). Synthetic lethal interaction between
sec24-20 and chromosomal deletion of SMY2 (Figure 3) is
also consistent with this idea. Finally, it is unlikely that
Smy2p modulates the GTPase cycle of Sar1p because the
overexpression of SMY2 did not suppress or exacerbate the
temperature-sensitive growth defect of the mutants, sec23-
1, sec23-2 (encoding a GAP for Sar1p), sec12-4 (encoding
a GEF for Sar1p) and sar1-2 (Table 1). Further extensive
biochemical studies will be necessary for understanding the
nature of defect in the sec24-20 mutant and the mode of its
suppression by Smy2p.
Mutational analysis of Smy2p revealed that its GYF
domain, a proline-rich sequence binding module, is
required for the suppression of the sec24-20 phenotypes
but not responsible for the interaction with Sec23p/Sec24p
subcomplex (Figure 8). This suggests that the GYF domain
mediates the interaction between Smy2p and another
protein that is also required for the suppression of the
sec24-20 phenotypes. Genome-wide two-hybrid analysis
has shown that Smy2p interacts with Msl5p and Mud2p,
nuclear proteins involved in messenger RNA splicing (58).
However, it is unlikely that these nuclear proteins facilitate
the COPII vesicle formation co-operatively with Smy2p on
the ER membrane. Identification of additional Smy2p-
interacting protein will be helpful to understand the
molecular mechanism by which Smy2p facilitates COPII
vesicle formation.
Finally, our work strongly suggests that Smy2p is an
accessory protein that facilitates COPII vesicle formation.
Recently, such putative accessory proteins have also been
identified on ER exit sites of mammalian cells. The
nucleoside diphosphate kinase Nm23H2 facilitates COPII
vesicle formation independent of its kinase activity (59).
The protein kinase PCTAIRE, which has been identified as
a Sec23p-interacting protein, requires its kinase activity for
ER exit of secretory cargo but not for the interaction with
Sec23p (60). In addition, the Ca
2þ-binding protein ALG-2
(apoptosis-linked gene 2) interacts with Sec31p in a Ca
2þ-
dependent manner (61), and the phospholipase A1-related
protein p125 interacts with Sec23p (62). These proteins
are possibly required for modulating COPII vesicle forma-
tion and/or organizing ER exit sites. Besides Sec16p,
Sed4p and the Yip1p–Yif1p–Yos1p complex (see Introduc-
tion), these findings together with our findings further
support the view that, in living cells, COPII vesicle forma-
tion is a more complicated process than that reconstituted
in vitro with minimal components. Identification and
detailed characterization of accessory proteins may pro-
vide novel insights into the regulation of COPII vesicle
formation under physiological conditions.
Materials and Methods
Yeast strains and media
Saccharomyces cerevisiae strains used in this study are listed in Table 3.
Cells were grown in MVD medium [0.67% yeast nitrogen base without
amino acids (Difco Laboratories Inc.) and 2% glucose], MCD medium [MVD
containing 0.5% casamino acids (Difco Laboratories Inc.)] or SC-raffinose
(0.67% yeast nitrogen base without amino acids, 0.06% dropout mix (63)
and 2% raffinose) with appropriate supplementations.
Plasmid construction
Construction of SEC24 plasmids, pAN1, pAN11 and pAN12, was described
previously (17). The DNA fragment containing SMY2 was obtained from
genomic DNA by polymerase chain reaction (PCR) with the primers
containing a SacIo rNotI restriction site at their 50 termini (50-AGAGA-
GAGGCGGCCGCATACATCTGTCACGTAAACCATTG-30 and 50-AGAGA-
GAGGAGCTCGTGCCTACTGTGTGCAAAGATATG-30), digested by SacI
and NotI and subcloned into the SacI–NotI sites of pRS426 (64) and
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DNA fragment containing YPL105c was obtained by PCR with the primers
containing a BamHI or EcoRI site at their 50 termini (50-AGAGAGAG-
GGATCCGTTTGATGGTCGAGGTGTCCTTCC-30 and 50-AGAGAGAGGAATTC-
CACTTCTCATCTCCATTAAGAACC-30), digested by BamHI and EcoRI and
subcloned into the BamHI–EcoRI sites of pRS426 to produce pYPL1. The
SMY2 gene with three repeated HA (3HA) epitopes at the carboxyl terminus
was generated as follows with pRS304-3HAc (a generous gift from K.
Kohno), a plasmid containingthe3HA epitopeswith a stop codonin the PstI–
EcoRI sites of pRS304 (65). The DNA fragment corresponding to the
downstream 500 bp of SMY2 was obtained by PCR with the primers
containing EcoRI and XhoI sites at their 50 termini (50-AGAGAGAGGAATTC-
TGAAAGGAAAAGCTTCATAATTT-30 and 50-AGAGAGAGCTCGAGTTCACGA-
GAAGGTGTTGAAGGCCG-30), digested with EcoRI and XhoI and subcloned
into the EcoRI–XhoI sites of pRS304-3HAc to produce pRS304-3HAc-UTR.
Then, the ORF of SMY2 with its upstream 250 bp was obtained by PCR with
the primers containing SacIo rPstI sites at their 50 termini (50-AGAGAGAG-
GAGCTCATACATCTGTCACGTAAACCATTG-30 and 50-AGAGAGAGCTG-
CAGCGTGTTTTCTACCCTTCTTCTTGCT-30), digested with SacIa n dPstI,
and subcloned into the SacI–PstI sites of pRS304-3HAc-UTR to produce
pRS304-SMY2-HAc-UTR. Finally, the DNA fragment containing SMY2-3HA
construct was obtained by the PvuII digestion of pRS304-SMY2-HAc-UTR
and subcloned into the PvuII site of pRS426 and pRS316 to produce pSMY2
and pSMY4, respectively. To create the mutant smy2 genes encoding the
proteins schematically represented in Figure 8A, the ORF of SMY2 with its
upstream 250 bpwas subjectedto PCR-mediated site-directedmutagenesis
with the primers corresponding to each mutation. As described above, the
resulting mutated ORFs were subcloned into pRS304-HAc-UTR, and then
the fragments containing mutant smy2-3HA construct were subcloned into
pRS316 to produce pSMY5 (mutant A) to pSMY13 (mutant I). pJG-SEC23,
pJG-SEC24, pEG-SEC24 and pEG-SMY2 are the plasmids for yeast two-
hybrid assay. Briefly, pJG-SEC23 and pJG-SEC24 are the plasmids that the
ORFs of SEC23 and SEC24 with their downstream 350 bp were fused in
frame with the B42 acidic activation domain at the XhoI site in pJG4-5
(OriGene TechnologiesInc.),respectively. pEG-SEC24is the plasmidthat the
ORF of SEC24 with its downstream 350 bp was fused in frame with the
LexA-DNA binding domain at the NotI site in pEG202 (OriGene Technologies
Inc.). Similarly, pEG-SMY2 was constructed with pEG202 and the ORF of
SMY2 with its downstream 550 bp.
Antibodies
The anti-Sec22p, anti-Sec23p, anti-Sec24p, anti-Sec31p and anti-Sec61p
antibodies were gifts from R. Schekman (University of California, Berkeley,
Table 3: Yeast strains used in this study
Strain Genotype Reference/Source
YPH500 MATa ura3 trp1 his3 leu2 lys2 ade2 (65)
YPH501 MATa/MATa ura3/ura3 trp1/trp1 his3/his3 leu2/leu2 lys2/lys2 ade2/ade2 (65)
YKH3 MATa ura3 trp1 his3 leu2 Dsec24::LEU2 containing pAN1
(SEC24, URA3, CEN)
(17)
YNH1 MATa ura3 trp1 his3 leu2 lys2 ade2 Dsec24::HIS3 containing pAN11
(SEC24, TRP1, CEN)
This study
YNH2 MATa ura3 trp1 his3 leu2 lys2 ade2 Dsec24::HIS3 containing pAN12
(sec24-20, TRP1, CEN)
This study
YNH3 MATa ura3 trp1 his3 leu2 Dsec24::LEU2 Dsmy2::HIS3 containing pAN1
(SEC24, URA3, CEN)
This study
YNH4 MATa ura3 trp1 his3 leu2 lys2 ade2 Dsmy2::HIS3 This study
YNH5 MATa ura3 his3 lys2 sec34-1 This study
YNH6 MATa ura3 trp1 leu2 lys2 sec35-1 This study
YNH7 MATa ura3 trp1 his3 leu2 Dsec24::LEU2 containing pAN12
(sec24-20, TRP1, CEN)
This study
YNH8 MATa ura3 trp1 his3 leu2 Dsec24::LEU2 Dsfb2::HIS3 containing pAN12
(sec24-20, TRP1, CEN)
This study
MBY10-7A MATa ura3 trp1 his3 his4 leu2 suc2 gal2 sec12-4 (4)
TOY224 MATa ura3 trp1 his3 leu2 lys2 ade2 Dsar1::HIS3 Dpep4::ADE2 containing pMYY3-9
(sar1E112K (sar1-2), TRP1, CEN)
(73)
RSY266 MATa ura3 his4 sec13-1 R. Schekman
a
RSY268 MATa ura3 sec16-2 R. Schekman
RSY270 MATa ura3 his4 sec17-1 R. Schekman
RSY11 MATa ura3 leu2 suc2 sec18-1 R. Schekman
RSY276 MATa ura3 his4 sec20-1 R. Schekman
RSY278 MATa ura3 his4 sec21-1 R. Schekman
RSY942 MATa ura3 lys2 sec22-3 R. Schekman
RSY282 MATa ura3 leu2 sec23-1 R. Schekman
RSY639 MATa ura3 leu2 sec23-2 R. Schekman
RSY1312 MATa ura3 trp1 leu2 sec27-1 R. Schekman
RSY1004 MATa ura3 leu2 sec31-1 R. Schekman
RSY958 MATa lys2 sec34-1 R. Schekman
RSY962 MATa lys2 sec35-1 R. Schekman
RSY944 MATa ura3 lys2 bet1-1 R. Schekman
EGY101 MATa ura3 trp1 his3 leu2 suc2 ret1-1 F. Letourneur
b
FLY89 MATa ura3 trp1 his3 leu2 suc2 ret3-1 F. Letourneur
EGY48 MATa ura3 trp1 his3 leu2::LexAop-LEU2 OriGene Technologies Inc.
aUniversity of California, Berkeley, Berkeley, CA, USA.
bUMR5086 CNRS/Universite Lyon I, Lyon, France.
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(University of Basel, Basel, Switzerland). The anti-CPY and anti-Kex2p
antibodies were described previously (66,67). Mouse monoclonal anti-
bodies, anti-HA, 16B12, 12CA5 and anti-Dpm1p, were purchased from
Berkeley Antibody, Roche Diagnostics and Molecular Probes.
Metabolic labeling and immunoprecipitation of
CPY and Gas1p
Pulse–chase experiments were performed as described previously (68,69).
Yeast cells grown exponentially in MCD medium were labeled with 25 mCi of
Redivue PRO-MIX [
35S] cell labeling mix (Amersham Pharmacia Biotech UK
Ltd.) per 1   10
7 cells and chased for appropriate times. Marker proteins,
CPY and Gas1p were recovered from the same cell lysates by immunopre-
cipitation with anti-CPY and anti-Gas1p at 1:500 dilution, resolved by SDS–
PAGE and visualized with a BAS2500 image analyzer (Fuji Photo Film).
Amounts of mature forms of CPY and Gas1p were quantified with IMAGE
GAUGEversion 3.45software(Fuji Photo Film) and expressed as%maturation.
Immunofluorescence microscopy
Indirect immunofluorescence was observed as described previously (17)
with the anti-HA (16B12) antibody as the primary antibody and fluorescein
5(6)-isothiocyanate-conjugated goat anti-mouse IgG (Cappel Research
Products, ICN, Inc.) as the secondary antibody. Nuclei were visualized by
DAPI staining. Preparations were observed with afluorescence microscope
BX-60 (Olympus) equipped with a confocal laser scanner unit CSU10
(Yokogawa Electric Corp.). Images were captured by a high-resolution
digital charge-coupled device camera ORCA-ER (Hamamatsu Photonics)
and processed with IPLAB software (Scanalytics Inc.).
Subcellular fractionation
Subcellular fractionation was performed as described previously (70) with
the following modification. A whole cell lysate prepared from log-phase
yeast cellswascentrifugedat100 000   g(model100AT4rotor;HitachiKoki
Co., Ltd.) for 20 min at 48C. The resulting pellet fraction wasresuspended in
sucrose solution [10 mM HEPES–KOH, pH 7.4, 1 mM ethylenediaminetetra-
acetic acid (EDTA) and 12.5% sucrose] containing protease inhibitors (2 mM
phenylmethylsulfonyl fluoride and 5 mg/mL each of chymostatin, leupeptin,
antipain, pepstatin A and aprotinin), placed on a 20–60% sucrose density
gradient and centrifuged at 217 000   g (at the bottom of the tube) (model
RPS-40T rotor; Hitachi Koki Co., Ltd.) for 2.5 h at 48C. Twelve fractions
were collected from the top and analyzed by SDS–PAGE and immunoblot-
ting. To characterize membrane association of Smy2p, a yeast cell lysate
was prepared and treated as follows. Log-phase yeast cells were spher-
oplasted and disrupted by agitation with glass beads in buffer 88 (20 mM
HEPES–KOH, pH 6.8, 250 mM sorbitol, 150 mM KOAc and 5 mM MgOAc)
containing protease inhibitors. Unbroken cells and debris were removed by
centrifugation at 500   g, and aliquots of the cleared whole cell lysate were
centrifuged at 100 000   g (model 100AT4 rotor; Hitachi Koki Co., Ltd.) for
20 min at 48C. The pellet fractions were resuspended in buffer 88, or buffer
88 containing 0.5 MNaCl, 2.5 M urea, 0.1 M Na2CO3 or 1% Triton-X-100, and
incubated on ice for 30 min. Samples were then centrifuged at
100 000   g (model 100AT3 rotor; Hitachi Koki Co., Ltd.) for 20 min at
48C, and the resulting pellet and supernatant fractions were analyzed by
SDS–PAGE and immunoblotting.
In vitro vesicle budding
Microsome preparation and in vitro vesicle budding reactions were per-
formed as described previously (70,71). The vesicle fraction was analyzed
by SDS–PAGE and immunoblotting.
Coimmunoprecipitation
For coimmunoprecipitation, log-phase yeast cells were spheroplasted
and disrupted by agitation with glass beads in lysis buffer (50 mM Tris–
HCl, pH 7.5, 150 mM NaCl, 5 mM EDTA and 5% glycerol) containing
protease inhibitors. After removing unbroken cells and debris, the whole
cell lysate was solubilized with 1% Triton-X-100 in immunoprecipitate (IP)
buffer (50 mM T r i s – H C l ,p H7 . 5 ,1 5 0m M NaCl, 5 mM EDTA and 5% skim
milk) containing protease inhibitors. After centrifugation at 17 400   g
for 30 min at 48C, the resulting supernatant was rotated overnight with
the protein G-immobilized anti-HA (12CA5) antibody at 48C. The beads
were washed four times with wash buffer (IP buffer without skim milk)
and boiled in the SDS–PAGE sample buffer (50 mM T r i s – H C l ,p H6 . 8 ,1 %
sodium dodecyl sulfate, 10% glycerol and 0.01% bromophenol blue)
containing 0.1 M dithiothreitol. The eluates were analyzed by SDS–PAGE
and immunoblotting.
Yeast two-hybrid assay
Sec23p and Sec24p were tested for binding to Smy2p with a DupLEX-A
yeast two-hybrid system (OriGene Technologies Inc.). EGY48 strains were
transformed with combinations of control or fusion protein plasmids
described under Plasmid construction together with a LacZ reporter
plasmid pSH18-34. The resulting transformants were grown to a log phase
in SC-raffinose medium, then galactose was added to a final concentration
of 2% and growth continued for 10 h. b-Galactosidase assay with per-
meabilized cells was performed as described previously (63).
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